General Updates

FOR THE ATTENTION OF THE SHAREHOLDERS OF MARKSANS PHARMA LIMITED SECOND 100 DAY CAMPAIGN - "SAKSHAM NIVESHAK" - FOR KYC AND OTHER RELATED UPDATIONS AND SHAREHOLDER ENGAGEMENT TO PREVENT TRANSFER OF UNCLAIMED DIVIDENDS TO IEPF Shareholders of Marksans Pharma Limited (“the Company”) are hereby informed that pursuant to Investor Education and Protection Fund Authority, Ministry of Corporate Affairs (MCA) letter, the Company has started a Second 100 Day campaign "Saksham Niveshak". During this Campaign, all the shareholders of the Company who have not claimed their Dividend for any Financial Years since 2018-19 or have not updated their KYC and nomination or any issues related to unclaimed dividends and shares, may contact the Company’s Registrar and Transfer Agent (RTA) i.e. Bigshare Services Private Limited at Office No. S6 - 2, 6th Floor, Pinnacle Business Park, Near Ahura Centre, Mahakali Caves Road, Andheri (East), Mumbai 400093; E-mail Id: investors@bigshareonline.com; Tel: 022 62638200 or may write to the Company Secretary of the Company at 11th Floor, Grandeur, Veera Desai Extension Road, Oshiwara, Andheri (W), Mumbai – 400053; Tel: 022 40012000 E-mail Id: companysecretary@marksanspharma.com. The shareholders may note that this campaign has been started specifically –  To help/enable the shareholders to claim their unclaimed dividend for the Financial Year 2018-19 and onwards before they get transferred to the Investor Education and Protection fund (IEPF).  To reach out to the shareholders to update their KYC details, Contact Details, Bank Account Details, choice of nomination and Specimen Signature.  To promote transparency and investor empowerment by ensuring direct claim processing without third parties. In case you are holding shares in physical form and your KYC details i.e. PAN linked with Aadhaar, Contact Details (postal address with PIN, Mobile Number and e-mail address), Bank Account Details (Bank Name and Branch, Bank Account Number, MICR, IFSC Code and cancelled cheque), choice of nomination and Specimen Signature are not yet registered, you are requested to submit relevant form viz. Form ISR-1, ISR-2, ISR-3, SH-13 and SH-14 along with the required supporting documents, for registration or updating KYC details. These forms can be downloaded from the website of the RTA i.e. https://www.bigshareonline.com/ or website of the Company i.e. https://www.marksanspharma.com/forms.html. Those shareholders who are holding shares in electronic form have to update / modify their details with their respective depository participants. As per our records, dividend declared by the Company from FY2019 to FY2025, as the case may be, have remained unclaimed in respect of certain shareholders. Details of such unclaimed dividend(s) are available on the website of the Company at https://www.marksanspharma.com/ . If you need help or have any questions, please feel free to reach out to us. Don’t miss out, submit your documents/claim before July 27, 2026. Thanking you, For Marksans Pharma Limited Harshavardhan Panigrahi Mumbai, July 17, 2026 Company Secretary & Compliance Officer Marksans Pharma Ltd. 11th Floor, "GRANDEUR", Opp. Gundecha Symphony, Veera Desai Extension Road, Oshiwara, Andheri (W), Mumbai - 400 053 Tel.: +91 22 4001 2000 E-mail: companysecretary@marksanspharma.com www.marksanspharma.com